
NVIDIA expands drug discovery platform, partners with Lilly
NVIDIA has announced a major expansion of NVIDIA BioNeMo, its open development platform for AI-driven biology and drug discovery, at the JP Morgan Healthcare Conference. The platform has expanded to include: New NVIDIA Clara open models, the RNAPro model for RNA structure prediction and the ReaSyn v2 model BioNeMo Recipes… Read More















